JPS52125609A - Purification of agglutination factor viii - Google Patents

Purification of agglutination factor viii

Info

Publication number
JPS52125609A
JPS52125609A JP3989476A JP3989476A JPS52125609A JP S52125609 A JPS52125609 A JP S52125609A JP 3989476 A JP3989476 A JP 3989476A JP 3989476 A JP3989476 A JP 3989476A JP S52125609 A JPS52125609 A JP S52125609A
Authority
JP
Japan
Prior art keywords
purification
factor viii
agglutination factor
agglutination
sephadex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3989476A
Other languages
English (en)
Other versions
JPS5512890B2 (ja
Inventor
Yoshiro Iga
Masashi Shiga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Green Cross Corp Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan filed Critical Green Cross Corp Japan
Priority to JP3989476A priority Critical patent/JPS52125609A/ja
Priority to US05/783,625 priority patent/US4093608A/en
Priority to DE2715832A priority patent/DE2715832C3/de
Publication of JPS52125609A publication Critical patent/JPS52125609A/ja
Publication of JPS5512890B2 publication Critical patent/JPS5512890B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
JP3989476A 1976-04-09 1976-04-09 Purification of agglutination factor viii Granted JPS52125609A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP3989476A JPS52125609A (en) 1976-04-09 1976-04-09 Purification of agglutination factor viii
US05/783,625 US4093608A (en) 1976-04-09 1977-04-01 Process for purifying coagulation factor VIII using DEAE-crosslinked dextran
DE2715832A DE2715832C3 (de) 1976-04-09 1977-04-07 Verfahren zur Gewinnung von gereinigtem antihämophilem Globulin A (Faktor VIII)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3989476A JPS52125609A (en) 1976-04-09 1976-04-09 Purification of agglutination factor viii

Publications (2)

Publication Number Publication Date
JPS52125609A true JPS52125609A (en) 1977-10-21
JPS5512890B2 JPS5512890B2 (ja) 1980-04-04

Family

ID=12565659

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3989476A Granted JPS52125609A (en) 1976-04-09 1976-04-09 Purification of agglutination factor viii

Country Status (3)

Country Link
US (1) US4093608A (ja)
JP (1) JPS52125609A (ja)
DE (1) DE2715832C3 (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4170639A (en) * 1978-07-10 1979-10-09 Warner-Lambert Company Antihemophilic factor concentrate and its production
DE2848529A1 (de) * 1978-11-09 1980-05-29 Behringwerke Ag Verfahren zur herstellung des kaelteunloeslichen globulins und dieses enthaltende arzneimittel
US4278594A (en) * 1979-06-19 1981-07-14 David Amrani Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
US4210580A (en) * 1979-06-19 1980-07-01 David Amrani Process for separation and isolation of AHF and fibronectin from blood plasma
US4294826A (en) * 1980-05-07 1981-10-13 Armour Pharmaceutical Company Process for the preparation of highly purified antihemophilic factor
AT368883B (de) 1980-07-22 1982-11-25 Immuno Ag Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen
EP0148843B2 (en) * 1983-03-21 1994-05-04 Novo Nordisk A/S A concentrate of the antihemophilic factor viii and a process for producing it
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
US5043428A (en) * 1984-08-31 1991-08-27 Behringwerke Aktiengesellschaft Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production
AT391808B (de) * 1986-11-03 1990-12-10 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion
EP0367840B1 (de) 1988-11-05 1993-02-03 Octapharma AG Verfahren zur Herstellung eines hochreinen, nicht infektiösen Antihämophiliefaktors mittels Chromatographie
DE3926034C3 (de) * 1989-08-07 1996-11-21 Behringwerke Ag Verfahren zur Herstellung eines stabilen Faktors VIII
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
US5770705A (en) * 1996-11-01 1998-06-23 Shanbrom Technologies Llc Method for recovering proteins from plasma using insoluble, water-absorbing material
MX2007002085A (es) 2004-08-20 2007-07-19 Prometic Biosciences Ltd Esquemas de aislamiento y purificacion consecutivos de proteinas mediante cromatografia de afinidad.
US9663553B2 (en) 2014-01-29 2017-05-30 Hemarus Therapeutics Limited Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4986515A (ja) * 1972-12-20 1974-08-19

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3717708A (en) * 1968-10-24 1973-02-20 Cutter Lab Blood coagulation complex
US3803115A (en) * 1972-05-17 1974-04-09 Baxter Laboratories Inc Stabilization of ahf using heparin
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4986515A (ja) * 1972-12-20 1974-08-19

Also Published As

Publication number Publication date
DE2715832C3 (de) 1980-01-03
DE2715832A1 (de) 1977-10-13
JPS5512890B2 (ja) 1980-04-04
DE2715832B2 (de) 1979-05-10
US4093608A (en) 1978-06-06

Similar Documents

Publication Publication Date Title
JPS52125609A (en) Purification of agglutination factor viii
JPS5268340A (en) Data processing unit
JPS5211823A (en) Digital display unit
JPS5247648A (en) Interruption control circuit
JPS5238098A (en) Cigarette filters
JPS5228174A (en) Tableware washing process and device
JPS5210056A (en) Quartz oscillator
JPS5359940A (en) High frequency heating system
JPS51129120A (en) Frequency change-over device
JPS51131964A (en) Filter device
JPS5213987A (en) Casing line of plural kinds small lot products
JPS5213157A (en) Potable freezer for light type freezer cabinet
JPS5217609A (en) Motor
JPS52100410A (en) Production of 3-isopropenyl-6-methyl-5-hepten-2-one
JPS5367851A (en) Filter apparatus
JPS537672A (en) 4-aminomethyl-5,6,7-trihydroxyisocoumarin
JPS5283704A (en) 2, 6, 11, 15-tetramethylhexadecane-6, 11-diol
JPS51148008A (en) Process for preparing therapeutic agents for leukemia
JPS51122742A (en) Input circuit for prothctive relay
JPS51127639A (en) Operation device
JPS51126584A (en) Vacuum chuck
JPS5419556A (en) Electric celaner
JPS5232795A (en) Case lock
JPS5242001A (en) Manufacturing method for carrying case
JPS5377045A (en) 2,4-bishomobrendan-2-one